Athira Pharma, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ATHA Nasdaq 2830 www.athira.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Athira Pharma, Inc.

Athira Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update - Nov 6th, 2025 2:05 pm
Athira Pharma Announces Reverse Stock Split - Sep 11th, 2025 7:00 am
Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025 - Aug 14th, 2025 5:00 am
Athira Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update - Aug 7th, 2025 2:05 pm
This Athira Pharma Insider Increased Their Holding By 111% Last Year - May 27th, 2025 7:16 am
Athira Pharma to present data from first-in-human Phase 1 trial of ATH-1105 - May 14th, 2025 9:10 am
Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit - May 13th, 2025 9:00 am
Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates - May 9th, 2025 2:05 pm
Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates - Feb 27th, 2025 2:05 pm
Can Athira Pharma (NASDAQ:ATHA) Afford To Invest In Growth? - Jan 28th, 2025 4:15 am
Athira Pharma Insider Ups Holding By 111% During Year - Dec 18th, 2024 5:19 am